Companies

Xenon Pharmaceuticals Inc. (XENE) SEC filings

CIK 0001582313 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in A1 · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2022FY2020
Revenue (USD)
Net income (USD)-28.8 M-41.6 M
Diluted EPS (USD/shares)-4.36-2.06

Latest filings

FiledFormDescriptionPeriod
2026-10-16442026-10-15
2026-10-01442026-09-30
2026-10-01442026-09-30
2026-09-03442026-09-01
2026-08-31442026-08-28
2026-08-28144144
2026-08-13442026-08-11
2026-08-13144144
2026-08-13SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-07SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-0610-Q10-Q2026-06-30
2026-08-068-K8-K items 2.02,7.01,9.012026-08-06
2026-08-06SCHEDULE 13G/ASCHEDULE 13G/A
2026-06-08442026-06-05
2026-06-08442026-06-05
2026-06-05144144
2026-06-05144144
2026-06-03442026-06-01
2026-06-03442026-06-01
2026-06-03442026-06-01
2026-06-03442026-06-01
2026-06-03442026-06-01
2026-06-03442026-06-01
2026-06-03442026-06-01
2026-06-03S-8 POSS-8 POS

Forms on file (last 1,000): 4 332, 8-K 142, SC 13G/A 47, 10-Q 36, 144 35, 3 33, 424B5 22, SC 13G 17. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=XENE (0.002 USD), /gw/filings/filings?ticker=XENE&form=8-K, /gw/filings/facts?ticker=XENE&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange